癌症数据库中的体质突变目录和结构建模分析人类癌症中CYP2D6突变的分析
Kennedy Kuchinski1, Nathaniel King1, Julia Driggers1
1Biology Department (K.K., K.L., M.V., S.S., E.S., W.E., H.W.) and Chemistry Department (N.K., J.D., C.S., R.L., S.A.M.), Xavier University, Cincinnati, Ohio; Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania (M.V.); and Department of Biology, California State University, Northridge (W.E.).
The Journal of pharmacology and experimental therapeutics
|October 8, 2024
概括
瘤内细胞染色体P450 2D6 (CYP2D6) 酶的突变可以改变癌症患者的药物代谢. 这项研究确定了关键的CYP2D6突变,有助于精准医学在癌症治疗中的方法.
科学领域:
- 药物基因组学 药物基因组学
- 癌症生物学 癌症生物学
- 结构生物学 结构生物学
背景情况:
- 细胞染色体P450 (CYP450) 酶,包括CYP2D6,对于药物代谢至关重要,影响化疗的疗效和毒性.
- 瘤表达的CYP450酶可以影响患者对癌症治疗的反应,需要了解它们的遗传变异.
- 已知CYP450基因中的单核酸多态 (SNP) 影响药物代谢,但它们在癌症中的特定作用需要进一步调查.
研究的目的:
- 在癌症患者中识别和描述CYP2D6酶的突变.
- 评估已识别的CYP2D6突变对蛋白质稳定性和药物结合的功能影响.
- 评估这些突变影响癌症药物代谢的潜力,并为精准医学策略提供信息.
主要方法:
- 从癌症体变异目录 (COSMIC) 数据库中对CYP2D6突变的分析.
- 使用计算工具 (CRAVAT,CHASMplus,VEST4) 来预测突变致病性和驱动状态.
- 使用Foldit Standalone和SwissDock进行结构分析,以评估对蛋白质稳定性和带结合的影响.
主要成果:
- 鉴定了CYP2D6中几个错误的突变,与蛋白质稳定性的改变有关.
- 三个错误的突变显著影响了对接稳定性,特别是那些靠近联结部位的α螺旋上的突变.
- 这些发现表明,瘤特异性CYP2D6突变可能会改变药物代谢.
结论:
- 已经确定了一系列与癌症病理学相关的CYP2D6突变.
- 这些突变可能会改变酶功能,影响瘤内的抗癌药物代谢.
- 这项研究为预测患者反应和指导癌症治疗中个性化药物选择和剂量提供了基础.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
01:39Mutations
80.8K
Overview
80.8K
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
01:12Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K